China SXT Pharmaceuticals, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2024: USD -1.89 M

China SXT Pharmaceuticals, Inc. EBITDA is USD -1.89 M for the Trailing 12 Months (TTM) ending March 31, 2024, a -62.28% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • China SXT Pharmaceuticals, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -5.01 M.
  • China SXT Pharmaceuticals, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2020 was USD -1.05 M, a -153.98% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)